AntiCan Cancer Research Results
AntiCan, Anticancer Effect: Click to Expand ⟱
| Source: |
| Type: general indicator |
Anticancer Effect
|
Nor, Normal Healthy: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
in-vivo, |
Liver, |
HepG2 |
|
|
|
- |
NA, |
Nor, |
NA |
|
|
|
*hepatoP↑, AntiCan↑,
| - |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
PC, |
MIA PaCa-2 |
|
|
|
- |
in-vitro, |
Pca, |
PC3 |
|
|
|
- |
in-vitro, |
Nor, |
HEK293 |
|
|
|
AntiCan↑, selectivity↑, Apoptosis↑, TumCCA↑, Bacteria↓, tumCV↓, selectivity↑, Apoptosis↑, TumCCA↑,
| - |
in-vitro, |
BC, |
4T1 |
|
|
|
- |
in-vivo, |
BC, |
4T1 |
|
|
|
- |
in-vitro, |
Nor, |
3T3 |
|
|
|
AntiCan↑, ROS↑, TumVol↓, EPR↑, selectivity↑, ChemoSen↑,
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
Nor, |
HEK293 |
|
|
|
NRF2↑, TumCCA↑, ROS↑, selectivity↑, *AntiViral↑, *toxicity↝, ETC↓, MMP↓, DNAdam↑, Apoptosis↑, lipid-P↑, other↝, UPR↑, *GRP78/BiP↑, *p‑PERK↑, *cl‑eIF2α↑, *CHOP↑, *JNK↑, Hif1a↓, AntiCan↑, *toxicity↓, eff↑,
| - |
in-vitro, |
Nor, |
L929 |
|
|
|
- |
in-vitro, |
Ovarian, |
SKOV3 |
|
|
|
AntiCan↑,
*NRF2↑, *DNMT1↓, *DNMT3A↓, *HDAC↓, *AntiCan↑,
*antiOx↑, *Inflam↓, *AntiDiabetic↓, AntiCan↑, *lipid-P↓, TumCP↓, Apoptosis↑, TumCCA↑, *SOD↑, *PGE2↓, *NO↓, *IL8↓, *IFN-γ↓, *cardioP↑, *NF-kB↓, *TNF-α↓, *BioAv↑,
*GutMicro↑, AntiCan↑, eff↑, AntiTum↑, ChemoSen↑,
| - |
Review, |
Nor, |
NA |
|
|
|
- |
Review, |
IBD, |
NA |
|
|
|
- |
Review, |
Diabetic, |
NA |
|
|
|
*Wound Healing↑, *Imm↑, *antiOx↑, *AntiDiabetic↑, *AntiCan↑, *Inflam↓, *NF-kB↓, *COX2↓, *5LO↓, *IL1β↓, *IL6↓, *TNF-α↓, *IL10↑, *other↓, *ROS↓, *SOD↑, *Catalase↑, *GPx↑, *lipid-P↓, *DNAdam↓, *GutMicro↑, *ZO-1↑, AntiTum↑, Casp3↑, Casp9↑, angioG↓, MMPs↓, VEGF↓, NK cell↑,
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vivo, |
BC, |
4T1 |
|
|
|
- |
in-vitro, |
Nor, |
MCF10 |
|
|
|
tumCV↓, AntiCan↑, *toxicity↓, Ferroptosis↑, i-Iron↑, GPx4↓, ROS↑, lipid-P↑, Tf↑, TumCG↓,
*AntiCan↑, *Inflam↓, *antiOx↑, *TRPV1↑, *AMPK↑, *SIRT1↑, *NADPH↓, *ROS↓, *MAPK↓, *eNOS↑, *Wnt/(β-catenin)↓, RenoP↑,
| - |
Review, |
Nor, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
*BBB↓, *GutMicro↑, Obesity↓, *Inflam↓, *AntiCan↑, *TRPV1↑, *Ca+2↑, *antiOx↑, *cardioP↑, *BioAv↓, *Half-Life↓, *BioAv↝, *BioAv↑, *neuroP↑, Apoptosis↑, p38↑, ROS↑, MMP↓, MPT↑, Cyt‑c↑, Casp↑, TRIB3↑, NADH↓, SIRT1↓, TumCG↓, TumCMig↓, TOP1↓, TOP2↓, β-catenin/ZEB1↓, *ROS↓, *Aβ↓,
*antiOx↑, *toxicity↓, *BioAv↓, *BioAv↑, *neuroP↑, *Obesity↓, *AntiCan↑, *TumCP↓, *PhotoS↑, *neuroP↑,
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Pca, |
HeLa |
|
|
|
- |
vitro+vivo, |
Melanoma, |
B16-BL6 |
|
|
|
- |
in-vitro, |
Nor, |
HEK293 |
|
|
|
TumCG↓, Ca+2↑, selectivity↑, *Ca+2∅, ROS↑, HSP70/HSPA5↑, AntiCan↑,
*Inflam↓, *AntiCan↑, *antiOx↑, *hyperG↓, *BG↓, *HbA1c↓, *NF-kB↓, *ROS↓, *TGF-β↑, *selectivity↑,
*AntiAge↑, *eff↑, *Inflam↓, *AntiCan↑, *ROS↓, *Catalase↑, *GSR↑, *HO-1↑, *NAD↑, *NQO1↑, *SOD↑, *NRF2↑,
| - |
in-vitro, |
GBM, |
A172 |
|
|
|
- |
in-vitro, |
Colon, |
Caco-2 |
|
|
|
- |
in-vitro, |
Pca, |
DU145 |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Nor, |
L929 |
|
|
|
*BioAv↑, selectivity↑, AntiCan↑, Apoptosis↑, CHOP↑, GADD34↑, BIM↑, PUMA↑, Ca+2↝,
| - |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Nor, |
HUVECs |
|
|
|
AntiCan↑, selectivity↓, *Bacteria↓, *antiOx↑, *toxicity↓, ROS↑, tumCV↓,
| - |
in-vitro, |
OS, |
143B |
|
|
|
- |
in-vitro, |
Nor, |
HEK293 |
|
|
|
- |
in-vivo, |
OS, |
NA |
|
|
|
AntiCan↑, *toxicity∅, Ferroptosis↑, ROS↑, lipid-P↑, GSH↓, p62↑, SLC12A5↓, eff↓, GPx4↓, i-Iron↑, eff↓, MDA↑, TumVol↓, TumW↓, Ki-67↓, LC3B↑, *Weight∅,
*antiOx↑, *Inflam↓, AntiCan↑, *ROS↓, *MDA↓, *GSH↓, *NRF2↑, *GPx↑, *GCLC↑, *GCLM↑,
*EP300↓, *mTORC1↓, *CRM↑, *HATs↓, *p62↓, *AntiAge↑, AntiCan↑,
*AntiCan↑, *Inflam↓, *antiOx↑, *AntiAge↑, *hepatoP↑, *cardioP↑, *neuroP↑, *eff↑,
Showing Research Papers: 1 to 22 of 22
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 22
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
Ferroptosis↑, 2, GPx4↓, 2, GSH↓, 1, i-Iron↑, 2, lipid-P↑, 3, MDA↑, 1, NADH↓, 1, NRF2↑, 1, ROS↑, 7,
Metal & Cofactor Biology ⓘ
Tf↑, 1,
Mitochondria & Bioenergetics ⓘ
ETC↓, 1, MMP↓, 2, MPT↑, 1,
Core Metabolism/Glycolysis ⓘ
SIRT1↓, 1,
Cell Death ⓘ
Apoptosis↑, 6, BIM↑, 1, Casp↑, 1, Casp3↑, 1, Casp9↑, 1, Cyt‑c↑, 1, Ferroptosis↑, 2, GADD34↑, 1, p38↑, 1, PUMA↑, 1,
Transcription & Epigenetics ⓘ
other↝, 1, tumCV↓, 3,
Protein Folding & ER Stress ⓘ
CHOP↑, 1, HSP70/HSPA5↑, 1, UPR↑, 1,
Autophagy & Lysosomes ⓘ
LC3B↑, 1, p62↑, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 1,
Cell Cycle & Senescence ⓘ
TumCCA↑, 4,
Proliferation, Differentiation & Cell State ⓘ
TOP1↓, 1, TOP2↓, 1, TumCG↓, 3,
Migration ⓘ
Ca+2↑, 1, Ca+2↝, 1, Ki-67↓, 1, MMPs↓, 1, TRIB3↑, 1, TumCMig↓, 1, TumCP↓, 1, β-catenin/ZEB1↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 1, EPR↑, 1, Hif1a↓, 1, VEGF↓, 1,
Barriers & Transport ⓘ
SLC12A5↓, 1,
Immune & Inflammatory Signaling ⓘ
NK cell↑, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 2, eff↓, 2, eff↑, 2, selectivity↓, 1, selectivity↑, 6,
Clinical Biomarkers ⓘ
Ki-67↓, 1, TRIB3↑, 1,
Functional Outcomes ⓘ
AntiCan↑, 14, AntiTum↑, 2, Obesity↓, 1, RenoP↑, 1, TumVol↓, 2, TumW↓, 1,
Infection & Microbiome ⓘ
Bacteria↓, 1,
Total Targets: 64
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 9, Catalase↑, 2, GCLC↑, 1, GCLM↑, 1, GPx↑, 2, GSH↓, 1, GSR↑, 1, HO-1↑, 1, hyperG↓, 1, lipid-P↓, 2, MDA↓, 1, NQO1↑, 1, NRF2↑, 3, ROS↓, 6, SOD↑, 3,
Core Metabolism/Glycolysis ⓘ
AMPK↑, 1, CRM↑, 1, NAD↑, 1, NADPH↓, 1, SIRT1↑, 1,
Cell Death ⓘ
JNK↑, 1, MAPK↓, 1, TRPV1↑, 2,
Transcription & Epigenetics ⓘ
HATs↓, 1, other↓, 1, PhotoS↑, 1,
Protein Folding & ER Stress ⓘ
CHOP↑, 1, cl‑eIF2α↑, 1, GRP78/BiP↑, 1, p‑PERK↑, 1,
Autophagy & Lysosomes ⓘ
p62↓, 1,
DNA Damage & Repair ⓘ
DNAdam↓, 1, DNMT1↓, 1, DNMT3A↓, 1,
Proliferation, Differentiation & Cell State ⓘ
EP300↓, 1, HDAC↓, 1, mTORC1↓, 1, Wnt/(β-catenin)↓, 1,
Migration ⓘ
5LO↓, 1, Ca+2↑, 1, Ca+2∅, 1, TGF-β↑, 1, TumCP↓, 1, ZO-1↑, 1,
Angiogenesis & Vasculature ⓘ
eNOS↑, 1, NO↓, 1,
Barriers & Transport ⓘ
BBB↓, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1, IFN-γ↓, 1, IL10↑, 1, IL1β↓, 1, IL6↓, 1, IL8↓, 1, Imm↑, 1, Inflam↓, 8, NF-kB↓, 3, PGE2↓, 1, TNF-α↓, 2,
Protein Aggregation ⓘ
Aβ↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 2, BioAv↑, 4, BioAv↝, 1, eff↑, 2, Half-Life↓, 1, selectivity↑, 1,
Clinical Biomarkers ⓘ
BG↓, 1, GutMicro↑, 3, HbA1c↓, 1, IL6↓, 1,
Functional Outcomes ⓘ
AntiAge↑, 3, AntiCan↑, 8, AntiDiabetic↓, 1, AntiDiabetic↑, 1, cardioP↑, 3, hepatoP↑, 2, neuroP↑, 4, Obesity↓, 1, toxicity↓, 4, toxicity↝, 1, toxicity∅, 1, Weight∅, 1, Wound Healing↑, 1,
Infection & Microbiome ⓘ
AntiViral↑, 1, Bacteria↓, 1,
Total Targets: 84
Scientific Paper Hit Count for: AntiCan, Anticancer Effect
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:49 Cells:% prod#:% Target#:813 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page